Respirology

NACI recommended that seniors who are 80 years and older, residents of long-term care homes, and adults and children six months and older who are moderately to severely immunocompromised should get two doses of COVID-19 vaccine per year.

Study compares twice-daily budesonide–glycopyrronium–formoterol (Breztri) metered-dose inhaler to daily fluticasone–umeclidinium–vilanterol (Trelegy) dry powder inhaler.